首页> 美国卫生研究院文献>BMJ Open Diabetes Research Care >Plasma fibroblast growth factor 21 levels increase with ectopic fat accumulation and its receptor levels are decreased in the visceral fat of patients with type 2 diabetes
【2h】

Plasma fibroblast growth factor 21 levels increase with ectopic fat accumulation and its receptor levels are decreased in the visceral fat of patients with type 2 diabetes

机译:2型糖尿病患者的内脏脂肪中血浆成纤维细胞生长因子21水平随异位脂肪积累而增加其受体水平降低

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Fibroblast growth factor 21 (FGF21) is a novel metabolic regulator that has beneficial effects on glucose and lipid metabolism. However, plasma FGF21 levels are paradoxically increased in type 2 diabetes mellitus (T2DM) and obesity, suggesting resistance to this ligand. FGF21 acts mainly on adipose tissue and ectopic fat accumulation is a typical feature in metabolic deterioration such as diabetes, metabolic syndrome, and cardiovascular disease.
机译:成纤维细胞生长因子21(FGF21)是一种新型的代谢调节剂,对葡萄糖和脂质代谢具有有益作用。然而,血浆FGF21水平在2型糖尿病(T2DM)和肥胖症中反常增加,表明对该配体具有抗性。 FGF21主要作用于脂肪组织,而异位脂肪堆积是代谢恶化(例如糖尿病,代谢综合征和心血管疾病)的典型特征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号